Mechanistic Insights of BME mediated inhibition of head and neck cancer growth
Mechanistic Insights of BME mediated inhibition of head and neck cancer growth
批准号:
9213362
负责人:
Ratna B. Ray
金额:
$37.88万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-02-15 至 2020-01-31
关键词:
AddressAlternative MedicineAmerican Cancer SocietyAnimal ModelBiologicalCell DeathCell LineClinical ResearchClinical TrialsCytotoxic ChemotherapyDataDevelopmentDiabetes MellitusDietDiseaseDistantEpidermal Growth Factor ReceptorEpitheliumFar EastFolk MedicineFoodFutureGenesGoalsGrowthHead and Neck CancerHead and Neck Squamous Cell CarcinomaHead and neck structureIn VitroLarynxLip structureMalignant Epithelial CellMalignant NeoplasmsMediatingMelonsModalityMolecularNasal cavityNatural Killer CellsNatural ProductsNoseOperative Surgical ProceduresOral cavityOutcomePatientsPharyngeal structurePlantsPre-Clinical ModelPreventionPreventiveQuality of lifeRadiationRadiation therapyRecurrenceRoleSignal PathwaySignal TransductionSignaling MoleculeSinusSupportive careSurvival RateTechniquesTestingTherapeuticTherapeutic AgentsTherapeutic EffectTongueTranslatingTreatment EfficacyUnited Statesbasec-myc Genescancer cellchemotherapyeffective therapyimmunoregulationimprovedinnovationinsightmouse modelnovelpre-clinicalpreventpublic health relevancestem-like celltargeted treatmenttherapy resistanttreatment strategytumor microenvironmenttumor progression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Head and neck squamous cell carcinoma (HNSCC) refers to a group of biologically similar cancers that start in the lip, tongue, oral cavity (mouth, nasal cavity (inside the nose), paranasal sinuses, pharynx, and larynx. HNSCC is the sixth most common cancer worldwide, and accounts for about 3-5% of all cancers in the United States. American Cancer society estimates 55,070 people will develop head and neck cancers in 2014. The 5- year survival rate of HNSCC patients is ~60% and has improved only marginally during the past few decades. Although improvements in surgical techniques, chemotherapy and radiation delivery, and supportive care have improved quality of life for patients with HNSCC, the regional and distant recurrence remain common and is almost always fatal. The impact of current cytotoxic therapies for HNSCC is limited by disease recurrence and resistance to therapy. Thus, there is a tremendous need for development of targeted and effective therapies. We have recently identified a plant-derived natural product, bitter melon extract (BME), which can induce HNSCC cell death. We have observed that BME treatment on HNSCC cells inhibits c-Met/EGFR and downstream signaling molecules (Stat3, c-myc and Mcl-1), and enhances natural killer (NK) cell activity, implicating its potential role in inhibition of head and neck cacer. The long-term objective of our project is to evaluate preventive and therapeutic efficacy of BME against HNSCC and understanding the underlying mechanisms. We hypothesize that BME and its active component(s) will prevent and inhibit HNSCC by multiple mechanisms including: modulation of genes critical to cancer progression, effect on cancer stem-like cells and tumor microenvironment in preclinical animal models. Results from this study will extend and translate our findings to future clinical studies. Innovation: Our application will examine for the first tim the mechanistic, preventive, and therapeutic effect of BME in highly relevant HNSCC animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mechanistic Insights of BME mediated inhibition of head and neck cancer growth
-
批准号:8892298
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Breast Cancer Prevention Using Bitter Melon as a Natural Product
-
批准号:9116142
-
项目类别:
-
资助金额:$16.48万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Developing new therapeutic strategies against head and neck cancer
-
批准号:10571845
-
项目类别:
-
资助金额:$48.37万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Developing new therapeutic strategies against head and neck cancer
-
批准号:10440075
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Mechanistic Insights of BME mediated inhibition of head and neck cancer growth
-
批准号:9414026
-
项目类别:
-
资助金额:$37.88万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Breast Cancer Prevention Using Bitter Melon as a Natural Product
-
批准号:8958249
-
项目类别:
-
资助金额:$19.77万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma
-
批准号:8872288
-
项目类别:
-
资助金额:$21.25万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Racial Disparity of microRNA in Hepatitis C Virus Mediated Hepatocellularcarcinoma
-
批准号:9042988
-
项目类别:
-
资助金额:$17.71万
-
财政年份:2015
-
负责人:Ratna B. Ray
-
依托单位:
Bitter melon and chemoprevention of prostate cancer
-
批准号:8037193
-
项目类别:
-
资助金额:$15.56万
-
财政年份:2010
-
负责人:Ratna B. Ray
-
依托单位:
Bitter melon and chemoprevention of prostate cancer
-
批准号:7895338
-
项目类别:
-
资助金额:$19.25万
-
财政年份:2010
-
负责人:Ratna B. Ray
-
依托单位:
Innate Immunity and Hepatitis C Virus Infection
-
批准号:8101849
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Innate Immunity and Hepatitis C Virus Infection
-
批准号:8299567
-
项目类别:
-
资助金额:$31.44万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Innate Immunity and Hepatitis C Virus Infection
-
批准号:7741066
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Innate Immunity and Hepatitis C Virus Infection
-
批准号:7900334
-
项目类别:
-
资助金额:$35.05万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Developing an in vitro system for HCV propagation
-
批准号:7924252
-
项目类别:
-
资助金额:$3.31万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
HCV infection, cross-talk among liver cells, and liver disease progression
-
批准号:9039872
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Innate Immunity and Hepatitis C Virus Infection
-
批准号:8516027
-
项目类别:
-
资助金额:$30.34万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
HCV infection, cross-talk among liver cells, and liver disease progression
-
批准号:9211304
-
项目类别:
-
资助金额:$34.09万
-
财政年份:2009
-
负责人:Ratna B. Ray
-
依托单位:
Developing an in vitro system for HCV propagation
-
批准号:7469295
-
项目类别:
-
资助金额:$18.31万
-
财政年份:2008
-
负责人:Ratna B. Ray
-
依托单位:
Developing an in vitro system for HCV propagation
-
批准号:7657339
-
项目类别:
-
资助金额:$15.26万
-
财政年份:2008
-
负责人:Ratna B. Ray
-
依托单位:
海外基金